Omaha, Neb., March 27, 2018 — The Society for Clinical Research Sites (SCRS) named Nicole Osborn, founder and CEO of Meridian Clinical Research, to its Leadership Council. As an experienced and committed executive of the research industry, Osborn will provide strategic guidance, policy decisions, and oversight for SCRS.
“We’re excited to welcome Nikki Osborn to our Leadership Council,” said SCRS president Christine Pierre. “Her decades of successful site management and entrepreneurship will be of tremendous value to the SCRS Leadership Council and our members.”
“SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability,” stated Osborn. “We champion advocacy, education, connectivity, and mentorship, and I’m proud to serve the members from more than 9,000 sites across 47 countries.”
Meridian is also the largest member of the Platinum Research Network, which Osborn co-founded.
To learn more about Meridian, visit www.mcrmed.com.
About Meridian Clinical Research
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit www.mcrmed.com.